Your fact-checks will appear here
Ivermectin is not approved for COVID-19 treatment
The products include oral tablets formulated to deliver approximately 200 mcg/kg for parasitic infections and a topical 1% cream (Soolantra) for , while are approved in multiple forms such as pour‑on ...
Ivermectin is a potent antiparasitic that is effective against many nematodes (roundworms) and some ectoparasites in humans—most notably strongyloidiasis, onchocerciasis (microfilariae), scabies and l...
Clinical trials of ivermectin for COVID‑19 range from small, early randomized studies to large community and hospital trials and multiple systematic reviews; results are mixed, with some meta-analyses...
Ivermectin for human use exists as oral tablets approved for specific parasitic infections and as approved for head lice and for inflammatory lesions of rosacea; the has not approved ivermectin for . ...
Horse ivermectin products are veterinary formulations of the antiparasitic drug ivermectin intended for large animals and are not approved or tested for human use . Using these products for COVID-19 o...